medigraphic.com
ISSN 0138-7103 (Print)

2014, Number 3

<< Back Next >>

Revista del Hospital Psiquiátrico de La Habana 2014; 11 (3)

Risk factors of the Alzheimer’s disease

Solórzano RJ, Gundián GM, Díaz MJP, Llibre GJJ

Language: Spanish
References: 28
Page:
PDF size: 118.72 Kb.


ABSTRACT

Cardiovascular risk factors were at the beginning more related to vascular dementia that to Alzheimer dementia (AD). However, during the last decades significant advances and researches have taken place and have increased the knowledge about Alzheimer disease. In addition, the last studies have found dissociation between the pathological brain findings and the symptoms of the AD. The limits between the cerebrovascular disease and the vascular dementia (DV) are difficult to define, many factors that are related to cerebrovascular disease and to the vascular dementia are related. Many cases of AD do have a simple pathogenesis. The post mortem studies on patients with AD and DV have shown the presence of cerebrovascular alterations in the firsts. And typical alterations of Alzheimer on the seconds. Also, that on both groups are shared common points such as elderly age and the vascular risk factors: High Blood Pressure (HBP), mellitus diabetes, obesity smoking addiction, hyperlipidemia, hyperhomocisteinemia y el haplotype E4 of Apolipoprotein E.


REFERENCES

  1. Rossetti H, Munro Cullum C, Linda S. Hynan L, et al. The CERAD Neuropsychologic Battery Total Store and the Progression of Alzheimer Disease. Alzheimer Dis Assoc Disord. 2010; 24.

  2. Llibre Rodriguez JJ, P Ferri C, Acosta D, Mariella Guerra, Yueqin Huang, K S Jacob, et al. Prevalence of dementia in Latin América, India, and China: a population-based crosssectional survey. Lancet. 2008; 372: 464–74.

  3. Correa de Toledo T, Alvesa, F, Kobuti Ferreiraa L, Wajngarten M, F. Busatto G. Cardiac Disorders as Risk Factors for Alzheimer’s disease. Journal of Alzheimer’s Disease: 2010.

  4. Rocchi A, Orsucci D, Tognoni G, Ceravolo R, Siciliano G.The role of vascular factors in late-onset sporadic Alzheimer’s disease. Genetic and molecular aspects. Curr Alzheimer Res. 2009. 6, 224.

  5. E. van den Berg, RP Kloppenborg, RPC Kessels, LJ Kappelle, GJ Biessels Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: A systematic comparison of their impact on cognition. Biochimica et Biophysica Acta. 2009.

  6. Presećki P, Mück-Seler D, MimicaHYPERLINK "http://preview.ncbi.nlm.nih.gov/pubmed?term=%22Mimica%20N%22%5BAuthor%5D" N, Pivac N, MustapićHYPERLINK "http://preview.ncbi.nlm.nih.gov/pubmed?term=%22Mustapi%C4%87%20M%22%5BAu thor%5D" M, Stipcević T, Smalc VF. Serum lipid levels in patients with Alzheimer's disease. 2011; 1:115-20.

  7. Wang CC, Lu TH, Liao WC, et al. Cigarette smoking and cognitive impairment: a 10-year cohort study in Taiwan. Arch Gerontol Geriatr. 2010; 51(2)

  8. Mielke MM, Leoutsakos JM, Tschanz JT, Green RC, Tripodis Y, Corcoran CD, Norton MC, Lyketsos CG. Interaction between Vascular Factors and the APOE E4 Allele in Predicting Rate of Progression in Alzheimer's Disease. J Alzheimers Dis. 2011 May.

  9. Bufill E, Bartés A, Moral A, Casadevall T, Codinachs M, Factores genéticos y ambientales que pueden influir en la forma senil de la enfermedad de Alzheimer: estudio de casos y controles anidado. Neurología 2009;24(2)

  10. Arango D, Cruts M, Torres O, Backhovens H, Serrano ML,Villareal E, y col. Systematic genetic study of Alzheimer disease in Latin America:mutation frecuencies of the amiloyd beta precursor protein and preselinines genes in Colombia. Am J Med Genet. 2001; 103.

  11. Umegaki H, Kawamura T, Kawano N, Umemura T, et al. Factors Associated with Cognitive Decline in Elderly Diabetics. Dement Geriatr Cogn Disord Extra 2011; 1.

  12. Anneloes L.M. Vlek, Frank L.J. Visseren, L. Jaap Kappelle, Mirjam I. Geerlings, Koen L. Vincken, Willem P. and Yolanda van der Graaf1.Blood Pressure and Progression of Cerebral Atrophy in Patients With Vascular Disease. Am J. Hypertens 2009; 22.

  13. Li, Y.J. Wang, M. Zhang, Z.Q. Xu, C.Y. Gao. Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease. Neurology 2011; 76.

  14. Juan de J. Llibre Rodríguez, Grupo Cubano de Investigación en Demencias. Trabajo para optar por el Premio Anual del Ministerio de Salud Publica, La Habana; 2011.

  15. Rodríguez Rivera, Luis. Llibre Rodríguez, Juan J. Práctica médica en las demencias. Editorial Ciencias Médicas. 2010. ISBN 978-959-212-620-6

  16. Kaffashian S, DugravotHYPERLINK "http://preview.ncbi.nlm.nih.gov/pubmed?term=%22Dugravot%20A%22%5BAuthor%5 D" A, Nabi H, Batty GD, Brunner E, KivimäkiHYPERLINK "http://preview.ncbi.nlm.nih.gov/pubmed?term=%22Kivim%C3%A4ki%20M%22%5BAu thor%5D" M, Singh-HYPERLINK "http://preview.ncbi.nlm.nih.gov/pubmed?term=%22Singh- Manoux%20A%22%5BAuthor%5D"Manoux A Framingham Stroke Risk Profile and poor cognitive function: a population-based study. BMC Neurol. 2008; 23.

  17. Velásquez M, Arcos-Burgos M,Toro M.E, Castaño A, Análisis factorial y descriminante de variables neuropsicólogicas en la demencia tipo Alzheimer de inicio tardío, familiar y esporádica.REV NEURL. 000; 31(6)

  18. Romero Ávila Yusimil, Comportamiento de variables clínicas y funcionales en pacientes con enfermedad de Alzheimer tardía. Consultorio médico 7. Policlínico Docente Ramón González Coro. 2010, Tesis de terminación de especialidad.

  19. Dimiter Hadjiev and Petya Mineva. Cerebral Blood Flow Changes in Elderly Hypertensive Patients and Cognitive. Stroke: 2007; 38; e153; originally published online Sep 13, 2007; Disponible en: www. stroke.ahajournals.org by on November 11, 2009.

  20. Presećki P, Mück-Seler D, Mimica N, Pivac N, Mustapić M, Stipcević T, Smalc VF. Serum lipid levels in patients with Alzheimer's disease. 2011; 1:115-20.

  21. Haag MD, Hofman A, Koudstaal PJ, Stricker BH, Breteler MM. Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study. J Neurol Neurosurg Psychiatry. 2009; 80(1):13-7.

  22. Wang CC, Lu TH, Liao WC, et al. Cigarette smoking and cognitive impairment: a 10-year cohort study in Taiwan. Arch Gerontol Geriatr. 2010; 51(2)

  23. Allam MF, Campbell MJ, Hofman A, Del Castillo AS, Fernández-Crehuet Navajas. R. Smoking and Parkinson’s disease: systematic review of prospective studies. Mov Disord. 2004; 19 (6)

  24. Tyas SL, White LR, Petrovitch H, et al. Mid-life smoking and late-life dementia: the Honolulu-Asia Aging Study. Neurobiol Aging. 2003; 24(4)

  25. Juan D, Zhou DH, Li J, Wang JY, Gao C, Chen M. A 2-year follow-up study of cigarette smoking and risk of dementia. Eur J Neurol. 2004; 11(4)

  26. Chengxuan C, Trastornos mentales orgánicos. Síntomas dependientes de la cultura. (Internet).2001(Citado15 Mayo 2005): (1pantalla).Disponible en: http://www.biopsicologia.net/fichas/page-5594.html

  27. Llibre Rodríguez Juan de Jesús, Valhuerdi Adolfo, Calvo Marina, Guerra Milagros. Dementia and Non Communicables diseases in Older Adults in Havana City and Matanzas Provinces, Cuba. MEDICC Review, October 2011, 12, (3)

  28. Evans DA, Hebert LE, Beckett LA., Scherr PA, (1997). Education and other measures of socio- economic status and risk of incident Alzheimer disease in a defined population of older persons. Arch Neurol997 Nov; 54 (11)




2020     |     www.medigraphic.com